☰

Mohammed Almoslem - Publications

Affiliations: 
2016-2018 Drug Discovery and Development Auburn University, Auburn, AL, United States 
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Almoslem M, Shah SD, Vozmediano V, Guzy S, Kim S, Hudak ML, Schmidt S. Pharmacokinetic and Pharmacodynamic Analysis of Acetaminophen and Ibuprofen Dual Therapy for Patent Ductus Arteriosus Closure in Preterm Neonates Less Than 29 Weeks' Gestation. Journal of Clinical Pharmacology. PMID 38015103 DOI: 10.1002/jcph.2386  0.467
2023 Rodriguez-Vera L, Yin X, Almoslem M, Romahn K, Cicali B, Lukacova V, Cristofoletti R, Schmidt S. Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin. Pharmaceutics. 15. PMID 37896246 DOI: 10.3390/pharmaceutics15102486  0.352
2022 Yamada W, Kim S, Almoslem M, Kim S, Myrick J, Nole J, Duncanson B, Louie A, Peloquin CA, Schmidt S, Drusano GL, Neely M. Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype. Antimicrobial Agents and Chemotherapy. e0069522. PMID 36165631 DOI: 10.1128/aac.00695-22  0.338
2021 Drusano GL, Rogers S, Brown D, Peloquin CA, Neely M, Yamada W, Kim S, Almoslem M, Schmidt S, Louie A. Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression. Antimicrobial Agents and Chemotherapy. PMID 33468465 DOI: 10.1128/AAC.02533-20  0.424
Show low-probability matches.